Genomic epidemiological determination of routes of pathogenic virus transmission between farmed salmon
Lead Research Organisation:
Royal Veterinary College
Department Name: Pathobiology and Population Sciences
Abstract
Viruses that cause disease and death in farmed salmon harm the UK's economy, increase the carbon and environmental footprint of production, and reduce fish welfare. Two viruses, called piscine myocarditis virus (PMCV) and infectious salmon anaemia virus (ISAV) are particularly damaging. For every eight salmon that die of known causes on fish farms, one death is caused by PMCV. ISAV is less commonly detected in the UK, and the UK is currently considered free of the disease. However, introductions of ISAV have been shown to nearly destroy entire salmon industries in other countries and therefore protecting against new outbreaks remains critical as the UK expands salmon production to meet growing global demand. Despite the severe problems caused by these viruses, we do not fully understand how they transmit between farms. Our lack of understanding of how viruses enter and persist on farms has prevented action that can improve disease control.
We propose to use virus genomic sequencing and genomic analyses to determine the routes of ISAV and PMCV transmission, and how and where pathogenic lineages emerge. Many viruses evolve very rapidly, and acquire genetic changes as they transmit between hosts. Using the evolved patterns of virus genetic changes to reconstruct ancestral relationships between viruses can be used to track how they transmit. Generated virus genomes additionally provide important information on the genetic basis for disease severity, and how pathogenic strains emerge. This approach has been widely used in public health to understand disease in humans, but opportunities to study disease transmission in farmed fish are being missed.
We will answer several key questions that will improve our understanding of how to eliminate transmission. Fish are moved between farms as they grow, from egg and progeny in tanks, to inland freshwater sites as juveniles, and finally to the sea at adulthood. Firstly, we will reconstruct transmission to determine whether each virus tends to transmit between farms at the same production stage, or between different stages. This would indicate where biosecurity improvements are best focused. Secondly, we will determine what characteristics of a farm make it more likely to become infected or transmit these viruses with other farms. Identified characteristics could be used to improve surveillance for viruses at certain points in the fish supply chain, leading to more rapid detection and control if viruses are present. Thirdly, we will determine whether wild fish are a source of infection of PMCV, or whether they only rarely become infected when they come into contact with infected farms. The distinction is important to determine whether wild fish can easily infect fish on farms, or whether in contrast wild fish must be better protected to prevent establishment of virus transmission within wild populations. Finally, we seek to understand how genetic changes in the virus lead to more or less severe disease. This could be used to improve genetic 'early warning systems' for risk of disease emergence in fish or improve vaccinations, and are more broadly useful to understand how related viruses evolve and cause disease in other species. The approaches that we use in this research will also be broadly applicable to viral diseases, improving our ability to rapidly respond to new viral outbreaks in humans and other animals
Together, our results will contribute to reducing disease amongst farmed salmon. This will lead to improved fish welfare, a more sustainable industry, cheaper cost of fish to the consumer because of reduction in loss, and greater economic value of the industry. Our results will be valuable to the UK, where salmon is the second most valuable food export, but also to producers and consumers in other markets worldwide.
We propose to use virus genomic sequencing and genomic analyses to determine the routes of ISAV and PMCV transmission, and how and where pathogenic lineages emerge. Many viruses evolve very rapidly, and acquire genetic changes as they transmit between hosts. Using the evolved patterns of virus genetic changes to reconstruct ancestral relationships between viruses can be used to track how they transmit. Generated virus genomes additionally provide important information on the genetic basis for disease severity, and how pathogenic strains emerge. This approach has been widely used in public health to understand disease in humans, but opportunities to study disease transmission in farmed fish are being missed.
We will answer several key questions that will improve our understanding of how to eliminate transmission. Fish are moved between farms as they grow, from egg and progeny in tanks, to inland freshwater sites as juveniles, and finally to the sea at adulthood. Firstly, we will reconstruct transmission to determine whether each virus tends to transmit between farms at the same production stage, or between different stages. This would indicate where biosecurity improvements are best focused. Secondly, we will determine what characteristics of a farm make it more likely to become infected or transmit these viruses with other farms. Identified characteristics could be used to improve surveillance for viruses at certain points in the fish supply chain, leading to more rapid detection and control if viruses are present. Thirdly, we will determine whether wild fish are a source of infection of PMCV, or whether they only rarely become infected when they come into contact with infected farms. The distinction is important to determine whether wild fish can easily infect fish on farms, or whether in contrast wild fish must be better protected to prevent establishment of virus transmission within wild populations. Finally, we seek to understand how genetic changes in the virus lead to more or less severe disease. This could be used to improve genetic 'early warning systems' for risk of disease emergence in fish or improve vaccinations, and are more broadly useful to understand how related viruses evolve and cause disease in other species. The approaches that we use in this research will also be broadly applicable to viral diseases, improving our ability to rapidly respond to new viral outbreaks in humans and other animals
Together, our results will contribute to reducing disease amongst farmed salmon. This will lead to improved fish welfare, a more sustainable industry, cheaper cost of fish to the consumer because of reduction in loss, and greater economic value of the industry. Our results will be valuable to the UK, where salmon is the second most valuable food export, but also to producers and consumers in other markets worldwide.
Technical Summary
Salmon is the second most valuable food export from the UK, and the most valuable fish product consumed nationally. Viruses in farmed salmon harm the UK's economy, decrease industry sustainability, and reduce fish welfare. Piscine myocarditis virus (PMCV) and infectious salmon anaemia virus (ISAV) are particularly damaging. Despite their impact, we do not understand how they transmit between farms because available case data is sparse and cannot be analysed to reconstruct transmission. Poor understanding about how these viruses spread has prevented action that can improve disease control and reduce disease incidence.
We will establish rapid genome sequencing and phylodynamic approaches to identify (i) how ISAV and PMCV spread, and (ii) where and how virus genetic variants emerge that cause severe disease. We focus on ISAV and PMCV transmission in the UK and in Norway: the UK's most important industrial partner. We will use discrete trait approaches to determine whether virus transmission tends to occur between salmon in the same phases of the supply chain (egg / juvenile freshwater phase / adult seawater phase) or as fish move through the supply chain. We will investigate whether wild fish help maintain PMCV. Using general linear model extensions to the phylogeographic approach, we will investigate whether certain farm characteristics, such as trading network centrality, are associated with higher transmission.
Virulent HPRdel ISAV lineages arise when a deletion occurs in the genome of a more common avirulent HPR0 precursor virus. We will use phylogeographic analyses to determine whether deletions tend to arise in certain production phases, and use phylogenetic approaches to detect whether virulence-conferring deletions only occur in the presence of permissive substitutions elsewhere.
Our results will contribute to better ability to prevent ISAV and PMCV transmission, leading to improved fish welfare, lower costs and improved industry sustainability.
We will establish rapid genome sequencing and phylodynamic approaches to identify (i) how ISAV and PMCV spread, and (ii) where and how virus genetic variants emerge that cause severe disease. We focus on ISAV and PMCV transmission in the UK and in Norway: the UK's most important industrial partner. We will use discrete trait approaches to determine whether virus transmission tends to occur between salmon in the same phases of the supply chain (egg / juvenile freshwater phase / adult seawater phase) or as fish move through the supply chain. We will investigate whether wild fish help maintain PMCV. Using general linear model extensions to the phylogeographic approach, we will investigate whether certain farm characteristics, such as trading network centrality, are associated with higher transmission.
Virulent HPRdel ISAV lineages arise when a deletion occurs in the genome of a more common avirulent HPR0 precursor virus. We will use phylogeographic analyses to determine whether deletions tend to arise in certain production phases, and use phylogenetic approaches to detect whether virulence-conferring deletions only occur in the presence of permissive substitutions elsewhere.
Our results will contribute to better ability to prevent ISAV and PMCV transmission, leading to improved fish welfare, lower costs and improved industry sustainability.
Organisations
| Description | Summer student research project |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | The student learned new skills in virus epidemiology and virus genomic sequencing, which they would otherwise have been unable to acquire during their degree programme. |
| Title | ISAV sequencing approach |
| Description | We have developed an approach for whole genome sequencing of ISAV via multiplexed bait capture using nanopore, which has allowed us to study the genomic diversity of ISAV. This approach has been tested on the European genotype, and will soon be tested on the American genotype. Once completed, the approach dataset will be shared with the community. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2023 |
| Provided To Others? | No |
| Impact | We have sequenced approximately 100 whole genomes of ISAV to date, more than doubling the number of whole genomes that are available. |
| Title | PMCV sequencing approach |
| Description | We have developed an approach for whole genome sequencing of PMCV, which has allowed us to study the genomic diversity of PMCV. This approach and dataset will be shared soon with the community. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2023 |
| Provided To Others? | No |
| Impact | Currently there is only 1 genome publicly available from piscine myocarditis virus. Our sequencing approach alllows new genomes to be easily and cheaply sequenced, therefore allowing better investigation of the genomic diversity, evolution and transmission of the virus. |
| Title | Infectious salmon anaemia virus genomes |
| Description | >100 whole genome infectious salmon anaemia virus genome sequences, from UK, Scotland and Canada |
| Type Of Material | Database/Collection of data |
| Year Produced | 2025 |
| Provided To Others? | No |
| Impact | The genome sequences will be made available on NCBI GenBank shortly, and are being used in analyses in our papers. |
| Title | Piscine myocarditis virus genomes |
| Description | Over 300 full genome sequences of piscine myocarditis virus genomes from the UK and Norway |
| Type Of Material | Database/Collection of data |
| Year Produced | 2025 |
| Provided To Others? | No |
| Impact | The genomes will be made publicly available on NCBI GenBank shortly, and are being used in our publications. |
| Description | Collaboration with Marine Scotland |
| Organisation | Marine Scotland Science (MSS) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | We are sequencing genomes from samples sent to us by Marine Scotland. |
| Collaborator Contribution | Marine Scotland is sharing samples and metadata related to previous outbreaks of PMCV and ISAV in Scotland. This includes extracting RNA for the project, and acquiring metadata. Access to these samples is important, because Marine Scotland hold older material than our other partners, which are needed to calibrate molecular clock and to investigate sporadic outbreaks of ISAV in the UK. |
| Impact | We have sequenced approximately 60 genomes to date from these samples, and have shared initial findings with our collaborator. |
| Start Year | 2023 |
| Description | Multi-lateral partnership with Pharmaq AS, Pharmaq Analytiq UK, and Institute of Marine Research |
| Organisation | Norwegian Institute of Marine Research |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | We are sequencing virus genomes from partners, and analysing the data to investigate the genetic diversity, evolutionary processes, and routes of spread associated with two fish viruses that infect farmed salmon (Salmo salar). |
| Collaborator Contribution | Our industrial partners offer a virus diagnostics service for salmon producers in the UK and Norway, and therefore already test samples from these countries for infectious salmon anaemia virus and piscine myocarditis virus. They have liaised with salmon farming companies to provide us with residual RNA and detailed metadata on these samples. They also provide extremely valuable expertise on salmon production systems, and interests and needs of producers regarding longterm management of these viruses. |
| Impact | The project is less than one year old, so publicly available outputs are still pending and require partner review before publication. We are now regularly receiving samples and metadata, and have begun to generate and analyse genomic datasets. |
| Start Year | 2022 |
| Description | Multi-lateral partnership with Pharmaq AS, Pharmaq Analytiq UK, and Institute of Marine Research |
| Organisation | Zoetis |
| Department | PHARMAQ AS |
| Country | Norway |
| Sector | Private |
| PI Contribution | We are sequencing virus genomes from partners, and analysing the data to investigate the genetic diversity, evolutionary processes, and routes of spread associated with two fish viruses that infect farmed salmon (Salmo salar). |
| Collaborator Contribution | Our industrial partners offer a virus diagnostics service for salmon producers in the UK and Norway, and therefore already test samples from these countries for infectious salmon anaemia virus and piscine myocarditis virus. They have liaised with salmon farming companies to provide us with residual RNA and detailed metadata on these samples. They also provide extremely valuable expertise on salmon production systems, and interests and needs of producers regarding longterm management of these viruses. |
| Impact | The project is less than one year old, so publicly available outputs are still pending and require partner review before publication. We are now regularly receiving samples and metadata, and have begun to generate and analyse genomic datasets. |
| Start Year | 2022 |
| Description | Marine Directorate visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | During a visit to Marine Directorate (Inverness), I presented our ongoing work to a mixed audience, including the Chief Scientific Officer. We discussed future plans, and the potential impact of the research. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Meetings with salmon producers in Norway |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | We visited approximately 4 fish farms around southern Norway (Bergen and Stavanger region), including sites that produce fish at different production stages (egg/smolt on three different sites with different levels of production intensity/adult stages in sea). We toured the facilities and met with fish health representatives from the companies that owned the sites, sharing our plans and preliminary findings. Since then, these producers have been more engaged in sharing samples and metadata related to the viruses that we study. We have a clearer understanding of the production systems and the needs of farmers, which improves our research. |
| Year(s) Of Engagement Activity | 2023 |
| Description | PHARMAQademy industry conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Online presentation as part of PHARMAQademy, an industry conference organised by a key industrial collaborator on this grant. The conference is attended by their customers (fish producing companies) and other professionals involved in aquaculture health. The aim of my presentation was to help engage fish producing companies in our research and the value of virus genomic epidemiology/genomic sequencing, and encourage them to participate by allowing us to use residual samples and data. The presentation set out the aims of the research, and how we intend to use the residual diagnostic samples and metadata that fish farmers are now providing us. PHARMAQ, who organised the conference, reported that participants were interested in our work. |
| Year(s) Of Engagement Activity | 2022 |
| Description | PHARMAQademy industry conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | I presented the updates of our research to approximately 70 representatives from the Scottish fish health and aquaculture community, including representatives from some of Scotland's largest salmon producing companies. Through this, we have recruited additional salmon producers to contribute samples to the study. |
| Year(s) Of Engagement Activity | 2024 |
| Description | PHARMAQademy industry conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Approximately 100 fish health professionals involved in salmon production in Scotland attended a talk providing an update on our work. We discussed the outcomes of our work, and possible future plans. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Presentation at AquaNor |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | This presentation took place following submission of this BBSRC grant, and directly arose from the collaboration formed with PHARMAQ AS when developing this grant. AquaNor is a hybrid trade fair that is arranged both physically in Trondheim and digitally, and is the world's largest aquaculture technology exhibition. In recent years, the Aqua Nor exhibition has drawn about 25,000 visitors from up to 76 nations. We presented aspects of the planned research to participants, to engage with producers and industry and inform them about the potential impact of genomic epidemiology of fish viruses on controlling outbreaks. Feedback from this meeting helped shape the early phases of research during the grant. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://aquanor.no/en/ |
